UNSPSC 51101656: Emodepside

This classification denotes an antihelminthic agent with the molecular formula C60H90N6O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YZ647Y5GC9. The term EMODEPSIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule emodepside under HS 29349990 and SITC 51579. As of Q4 2014, EMODEPSIDE remains the US FDA Preferred Term for this commodity. Emodepside bears US NLM identifiers UMLS ID C1172566 and NCI Concept Code C90726.

SMILES: CC1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C.

UNSPSC 51101656 Emodepside is a Commodity code that nominally designates a specific antiparasitic pharmaceutical product, but recent state and local solicitations tagged with this code show minimal direct alignment with emodepside itself. Instead, the code appears in procurement records for broader pharmaceutical and medical supply acquisitions, including naloxone procurement, generic multi-source pharmaceuticals, over-the-counter products, and first-aid medical supplies for emergency response. State and local buyers using this code include county health departments, state pharmacy benefit programs, municipal fire departments, and multistate cooperative purchasing alliances. The scope of work spans finished pharmaceutical and OTC product procurement, with vendors supplying through authorized wholesalers, meeting FDA and cGMP compliance, managing NDC coding and inventory tracking, and delivering within specified shelf-life and expiration-date windows. Issuing bodies range from large cooperative purchasing vehicles (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon) to single municipalities (City of Tampa Fire Department) and state health agencies (Texas Health and Human Services Commission).

Geographic activity centers on Florida, Minnesota, Texas, and Oregon, based on recent solicitations. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, estimated at an undisclosed amount with a two-year initial term and one-year renewal option; the Minnesota Multistate Cooperative Purchasing Alliance RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities with a July 1, 2026 contract start; the City of Tampa's IFB 26P00145 (due March 13, 2026) for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division, estimated at $700,000.00 and designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount; and the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) gathering vendor capability information on direct-to-manufacturer prescription programs. The mismatch between the code's nominal emodepside designation and actual procurement scope suggests potential tagging variance in source systems.